Pharmafile Logo

Chester Medical Solutions

Chester Medical Solutions is one of the UK’s leading providers of contract assembly and manufacturing services to ethical, generic and medical device brand owners, working in partnership with some of the industry’s most prominent companies. With Chester Medical, our aim has been to build upon our experience and knowledge by adding to our portfolio of services to create a genuine ‘one-stop-shop’. We are now in a position to offer an unrivalled range of in-house contract services.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

Units 3 & 4 Apex Court, Bassendale Road, Bromborough, Wirral, CH62 3RE, United Kingdom
+44 (0)1244 288 136

 Latest Content from PMHub 

Pegasus Moves to Brighton

Press Releases | April 29, 2014 | Inizio

Top UK Healthcare Communications Consultancy Moves to Brighton

UX: Designing Human Experiences

Applying science to the creative process to improve lives

08 UX: Pushing the right buttons

Unlocking better outcomes in healthcare with UX

UX: Pushing the right buttons

Unlocking better outcomes in healthcare with UX

07 Good Pharma

Better for patients, better for business

05 Social Media: A Health Hazard?

The case to embrace going social

Creating a Lifeline to the New Digital User

Today, we’re focussed on getting to know our new target: she’s online, mobile, and connected to a large network of friends, information, and marketers who help her make decisions about...

Warehousing of HCV patients reaches new high

White Papers and Resources | December 19, 2013 | Inizio

A new study conducted by Research Partnership reveals that 90% of physicians treating HCV patients in the US have reported they are now “warehousing” patients (holding off treatment) in expectation...

Brand leaders in RA will lose market share, predict rheumatologists

White Papers and Resources | December 19, 2013 | Inizio

Rheumatologists believe that the current market for biologic treatments in Rheumatoid Arthritis (RA) will see key changes in the next three years.